探索使用基于HME的丝材制造的传统和FDM介导的3D打印片,用于pH依赖的药物输送
Ruchira Patil1, Prajakta Bule1, Naveen Chella2
1Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research, Sila Village, Changsari, Kamrup District, Guwahati, Assam, India, 781101.
AAPS PharmSciTech
|March 28, 2025
概括
热挤出与3D打印相结合,成功地创建了无形的纳林根因纤维,用于针对结肠的药物输送. 这种方法对个性化炎症性肠病治疗有希望.
科学领域:
- 制药技术 制药技术 制药技术
- 药物输送系统 药物输送系统
- 材料科学 材料科学 材料科学
背景情况:
- 热挤出 (HME) 提高了难以溶解的BCSII和IV类药物的溶性.
- 对HME细丝的下游加工对于最终剂型的开发至关重要.
- 炎症性肠病 (IBD) 需要有效的针对结肠的药物输送.
研究的目的:
- 为了研究HME和沉积建模 (FDM) 3D打印的组合,用于结肠特异性naringenin的输送.
- 为在结肠中局部释放药物开发pH敏感的HME纤维.
- 探索3D打印对于个性化IBD治疗的潜力.
主要方法:
- 使用HME,用基甲基纤维素乙酸酸盐,聚乙烯甘醇 (PEG 4000) 和Aerosil 200制造纤维.
- 通过差分扫描热度计和粉末X射线衍射证实了纳灵宁的无形状态.
- 通过压缩和FDM3D打印生产了片,药物释放在不同的pH值水平上进行了评估.
主要成果:
- 经过优化后的细丝表现出pH取决于naringenin的释放 (0.03%在pH1.2下,11.52%在pH6.8下,77.80%在pH7.4下).
- 压缩和3D打印的片子都含有无形宁,并显示了pH依赖的零序释放动力学.
- FDM 3D打印平板电脑尺寸和灌装密度显著影响了药物释放,证明了可调节的药物输送.
结论:
- 结合HME和FDM3D打印是一种可行的策略,用于开发针对结肠的naringenin输送系统.
- 开发的技术可以通过调整3D打印平板电脑参数来实现个性化医疗.
- 这些发现支持在临床前和临床环境中对IBD进行进一步的研究.
更多相关视频
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
834
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
834
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
420
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
420
Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Drug Delivery Systems: Different Types
406
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
406
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164


